BKV Corp. Files 8-K Report
Ticker: BKV · Form: 8-K · Filed: Dec 18, 2025 · CIK: 1838406
| Field | Detail |
|---|---|
| Company | Bkv Corp (BKV) |
| Form Type | 8-K |
| Filed Date | Dec 18, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $100 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, sec-filing
TL;DR
BKV Corp. filed an 8-K on 12/18/25, confirming Denver HQ.
AI Summary
On December 18, 2025, BKV Corp. filed an 8-K report. The filing indicates the company's principal executive offices are located at 1200 17th Street, Suite 2100, Denver, Colorado, 80202. The report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This 8-K filing serves as an official notification to the SEC and the public regarding BKV Corp.'s corporate information and reporting status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently poses a significant risk.
Key Players & Entities
- BKV Corp. (company) — Registrant
- December 18, 2025 (date) — Date of Report
- 1200 17th Street, Suite 2100, Denver, Colorado, 80202 (address) — Principal executive offices
- Securities Exchange Act of 1934 (legal_document) — Governing Act
FAQ
What is the primary purpose of this 8-K filing for BKV Corp.?
The primary purpose is to report current information as required by Section 13 or 15(d) of the Securities Exchange Act of 1934, including details about the company's principal executive offices.
When was this 8-K report filed by BKV Corp.?
The 8-K report was filed on December 18, 2025.
What is the official address of BKV Corp.'s principal executive offices mentioned in the filing?
The address listed for BKV Corp.'s principal executive offices is 1200 17th Street, Suite 2100, Denver, Colorado, 80202.
Under which sections of the Securities Exchange Act of 1934 is this 8-K filing made?
The filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is BKV Corp.'s state of incorporation and IRS Employer Identification Number?
BKV Corp. is incorporated in Delaware and its IRS Employer Identification Number is 85-0886382.
Filing Stats: 730 words · 3 min read · ~2 pages · Grade level 12.3 · Accepted 2025-12-18 07:34:03
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share BKV New York Stock Exchan
- $100 million — or an aggregate purchase price of up to $100 million through open market purchases, block tr
Filing Documents
- tm2533737d1_8k.htm (8-K) — 28KB
- tm2533737d1_ex99-1.htm (EX-99.1) — 10KB
- tm2533737d1_ex99-1img001.jpg (GRAPHIC) — 3KB
- 0001104659-25-122294.txt ( ) — 209KB
- bkv-20251218.xsd (EX-101.SCH) — 3KB
- bkv-20251218_lab.xml (EX-101.LAB) — 33KB
- bkv-20251218_pre.xml (EX-101.PRE) — 22KB
- tm2533737d1_8k_htm.xml (XML) — 4KB
01. Other Events
Item 8.01. Other Events. On December 18, 2025, BKV Corporation (the "Company") announced that its Board of Directors (the "Board") authorized a two-year share repurchase program pursuant to which the Company may repurchase from time to time shares of its common stock, par value $0.01 per share ("Common Stock"), for an aggregate purchase price of up to $100 million through open market purchases, block trades, 10b5-1 plans, or by means of privately negotiated purchases, in each case subject to compliance with the applicable provisions of federal and state securities laws and regulations, including Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The timing and total amount of any share repurchases will be determined at the discretion of the Company's management based on a variety of factors, including economic and market conditions, the stock price, the Company's liquidity requirements and priorities, regulatory requirements, applicable legal requirements and other factors. The repurchase program does not obligate the Company to repurchase any specific number of shares and may be suspended, modified, or discontinued at any time at the discretion of the Board. Share repurchases are expected to be funded through available cash or borrowings under the Company's existing reserve-based lending agreement. This Form 8-K contains "forward-looking program. Investors are cautioned not to place undue reliance on these forward-looking statements, which are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements, including the risks and uncertainties addressed under the heading "Risk Factors" in BKV's most recent Annual Report on Form 10-K filed and any subsequent Quarterly Reports on Form 10-Q. These forward-looking statements speak only as
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated December 18, 2025, announcing the approval of a share repurchase program. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BKV Corporation December 18, 2025 By: /s/ David R. Tameron David R. Tameron Chief Financial Officer